Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
Strengthening capabilities in Peptide Therapeutics and CDMO services
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Subscribe To Our Newsletter & Stay Updated